35 related articles for article (PubMed ID: 16261198)
1. Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 Infection.
Nodarse-Cuni H; Bravo O; Cañete R; Vázquez-Blomquist D; Quintana D; Aguilera-Barreto A; Guillen-Nieto G; Arteaga A; Morales I
J Interferon Cytokine Res; 2024 Jun; 44(6):271-280. PubMed ID: 38597374
[TBL] [Abstract][Full Text] [Related]
2. Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System.
Anaeigoudari A; Mollaei HR; Arababadi MK; Nosratabadi R
Inflammation; 2021 Dec; 44(6):2151-2169. PubMed ID: 34524614
[TBL] [Abstract][Full Text] [Related]
3. Potential Prophylactic Treatments for COVID-19.
Ben-Zuk N; Dechtman ID; Henn I; Weiss L; Afriat A; Krasner E; Gal Y
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372498
[TBL] [Abstract][Full Text] [Related]
4. Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents.
Cegolon L; Javanbakht M; Mastrangelo G
Int J Hyg Environ Health; 2020 Sep; 230():113605. PubMed ID: 32898838
[TBL] [Abstract][Full Text] [Related]
5. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.
Shen K; Yang Y; Wang T; Zhao D; Jiang Y; Jin R; Zheng Y; Xu B; Xie Z; Lin L; Shang Y; Lu X; Shu S; Bai Y; Deng J; Lu M; Ye L; Wang X; Wang Y; Gao L; ; ; ; ; ; ; ; ; ;
World J Pediatr; 2020 Jun; 16(3):223-231. PubMed ID: 32034659
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue.
Shen KL; Yang YH
World J Pediatr; 2020 Jun; 16(3):219-221. PubMed ID: 32026147
[No Abstract] [Full Text] [Related]
8. Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.
Barnard DL; Kumaki Y
Future Virol; 2011 May; 6(5):615-631. PubMed ID: 21765859
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits.
Gao L; Yu S; Chen Q; Duan Z; Zhou J; Mao C; Yu D; Zhu W; Nie J; Hou Y
Vaccine; 2010 Jun; 28(28):4445-51. PubMed ID: 20394720
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
Sims AC; Burkett SE; Yount B; Pickles RJ
Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
[TBL] [Abstract][Full Text] [Related]
11. [Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP
Antibiot Khimioter; 2011; 56(9-10):41-6. PubMed ID: 22586904
[TBL] [Abstract][Full Text] [Related]
12. [Preventive and therapeutic effects of recombinant IFN-alpha2b nasal spray on SARS-CoV infection in Macaca mulata].
Gao H; Zhang LL; Wei Q; Duan ZJ; Tu XM; Yu ZA; Deng W; Zhang LP; Bao LL; Zhang B; Tong W; Hou YD; Zhang BL; Huang L; Qin C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):207-10. PubMed ID: 16261198
[TBL] [Abstract][Full Text] [Related]
13. SARS treatment. Interferon shows promise in monkeys.
Enserink M
Science; 2004 Feb; 303(5662):1273-5. PubMed ID: 14988528
[No Abstract] [Full Text] [Related]
14. In vitro inhibition of SARS virus replication by human interferons.
Dahl H; Linde A; Strannegård O
Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169
[TBL] [Abstract][Full Text] [Related]
15. [A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections].
Yu DX; Chen Q; Zhang LL; Liu Y; Yu ZA; Li ZF; Zhang LP; Hu GF; Duan ZJ; Chu XW; Zhang B; Yu SY; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):216-9. PubMed ID: 16261200
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
